| |
|
|
|
Aldeyra Therapeu  
|
|
11.27 -0.64 (-0.05%) |
03-04 11:16 |
|
Open: |
11.79 |
Pre close: |
11.91 |
Target:
|
15.09
|
|
High: |
12.12 |
Low: |
10.91 |
Resistance:
|
12.92
14.52
|
|
Volume: |
291,225 |
Market Cap: |
515M |
Support:
|
10.33
8.59
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
12.03
 |
MACD |
MACD(12,26):
|
0.23 |
|
MA(20): |
12.28 |
Signal(12,26,9): |
0.43 |
|
MA(100): |
8.89  |
Stochastic Oscillator |
%K(14,3):
|
33.80 |
|
MA(250): |
6.46 |
%D(3): |
39.62 |
|
Average Volume(K) |
3-Month: |
112807
|
52-Week |
High:
|
14.62 |
|
10-Days: |
57594 |
Low: |
1.48 |
|
RSI |
RSI(14):
|
46.77 |
Change(%): |
222.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.260 |
Return on Equity (ttm) |
-65.7 |
Shares Out. (M) |
45.66 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-28.6 |
Shares Float (M) |
31.08 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.28 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
67.35 |
|
Forward EPS |
-2.240 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1990 |
|
Book Value (p.s.) |
1.790 |
EBITDA (p.s.) |
-0.826 |
P/E |
-9.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.33 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-40.40 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.98 |
P/CF |
-12.81 |
|
|
|
|
|
|
